Back
Supernus Pharmaceuticals Stock Predictions
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
38
SUPN
Supernus Pharmaceuticals
Last Price:
30.09
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.Supernus Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 25.9% based on the past 11 years of stock performance.
- Supernus Pharmaceuticals has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Supernus Pharmaceuticals Stock Undervalued?
The current Supernus Pharmaceuticals [SUPN] share price is $30.06. The Score for SUPN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 25.9% based on the past 11 years of stock performance.
Supernus Pharmaceuticals Stock Rating
Sell
38
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals overpriced?
- Supernus Pharmaceuticals has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Supernus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
38.09
52-Week Low:
21.99
Prediction Charts
Market Cap:
1.65B
Price in USD:
30.06
Volume:
348.1K
Beta:
1.13
Technical Analysis
SMA50:
31.52
SMA100:
29.76
SMA200:
29.08
52-Wk Change:
-18.65%
Stock Predictions
-
Is Supernus Pharmaceuticals stock public?
Yes, Supernus Pharmaceuticals is a publicly traded company. -
What is the Supernus Pharmaceuticals stock quote today?
The Supernus Pharmaceuticals stock price is 30.06 USD today. -
How to buy Supernus Pharmaceuticals stock online?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-12 | 31.98 | 30.24 | 31.98 | 30.08 |
| Apr-15 | 30.51 | 29.99 | 30.60 | 29.68 |
| Apr-16 | 30.00 | 29.43 | 30.40 | 29.35 |
| Apr-17 | 29.74 | 28.99 | 30.08 | 28.88 |
| Apr-18 | 28.87 | 28.88 | 29.48 | 28.63 |
| Apr-19 | 28.67 | 29.42 | 29.53 | 28.67 |
| Apr-22 | 29.56 | 29.71 | 30.30 | 29.28 |
| Apr-23 | 29.75 | 29.98 | 31.84 | 29.59 |
| Apr-24 | 29.96 | 30.26 | 30.40 | 29.82 |
| Apr-25 | 30.03 | 29.31 | 30.22 | 29.17 |
| Apr-26 | 29.46 | 30.07 | 30.19 | 29.17 |
| Apr-29 | 30.35 | 30.60 | 31.27 | 30.35 |
| Apr-30 | 30.40 | 30.09 | 30.70 | 30.03 |
| May-1 | 30.15 | 30.06 | 30.69 | 29.99 |
Supernus Pharmaceuticals Earnings
Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals Forecast Revenue Growth
Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.35 per share, and an increase next year of $0.31 per share.
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.